QDEL Stock Analysis: Buy, Sell, or Hold?
QDEL - QuidelOrtho Corporation Common Stock
$12.37
-1.30 (-9.51%)
▼
5d:
-12.46%
30d:
+3.86%
90d:
-18.83%
WAIT
LOW Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Get Alerted When QDEL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: QDEL is down 12.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: QDEL is down 12.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$36.60
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$22.73
45.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: QDEL is currently trading at $12.37, which is considered slightly low relative to its 30-day fair value range of $11.87 to $14.28. From a valuation perspective, the stock is trading at a discount (Forward PE: 5.1) compared to its historical average (7.7). Remarkably, the market is currently pricing in an annual earnings decline of 13.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, QDEL is in a strong downtrend. The price is currently testing key support at $12.63. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 9.5% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (16th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $18.62 (+50.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, QDEL is in a strong downtrend. The price is currently testing key support at $12.63. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 9.5% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (16th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $18.62 (+50.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$11.87 -
$14.28
Company Quality Score
52/100
(HOLD)
Options IV Signal
16th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
79.6%
Protect Your Profits
Holding QDEL? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 16th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-9.5%)
- BULLISH: Trading 50.6% below Wall St target ($18.62)
- WARNING: Recommendation downgraded due to -12.5% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$11.87 -
$14.28
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
±$1.53
(12.3%)
Support & Resistance Levels
Support Level
$12.63
Resistance Level
$15.16
Current Trend
Strong Downtrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
5.07
Wall Street Target
$18.63
(+50.6%)
Revenue Growth (YoY)
-10.5%
Earnings Growth (YoY)
-77.1%
Profit Margin
-45.6%
Valuation Discount vs History
-13.0% cheaper
PE vs Historical
5.1 vs 7.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-13.0%
(market-implied from PE analysis)
1-Year Target
$11.13
(-10%)
2-Year Target
$10.02
(-19%)
3-Year Target
$9.02
(-27%)
3-Yr Target (if PE normalizes)
(PE: 5→8)
$13.70
(+11%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 29.3%)
$114.81
(+828%)
Base:
(SPY PE: 5.1, Growth: 29.3%)
$26.71
(+116%)
Bear:
(PE: 4.3, Growth: 29.3%)
$22.71
(+84%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 5.1 to 7.7
Stabilization Target:
$18.80
(+51.9%)
PE Expansion Potential:
+51.9%
Share & Embed Analysis
Last updated: June 23, 2026 8:38 AM ET
Data refreshes hourly during market hours. Next update: 9:38 AM
Data refreshes hourly during market hours. Next update: 9:38 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QDEL showing a specific setup today?
Insider Activity (6 Months)
3
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Brian J Blaser
BUY
10540 shares
2026-02-13
Joseph M Busky
BUY
3370 shares
2026-02-13
Matthew Strobeck
BUY
10000 shares
2026-02-13
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 52 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 61 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 59 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 60 HOLD |
Advanced QDEL Option Strategies
Professional options setups generated by AI based on today's QDEL price and gamma walls.
